Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bluejay Diagnostics (BJDX) Share-based Compensation (2022 - 2023)

Bluejay Diagnostics' Share-based Compensation history spans 2 years, with the latest figure at -$15565.0 for Q4 2023.

  • For Q4 2023, Share-based Compensation fell 117.77% year-over-year to -$15565.0; the TTM value through Dec 2023 reached $189245.0, down 56.29%, while the annual FY2024 figure was $20094.0, 89.38% down from the prior year.
  • Share-based Compensation for Q4 2023 was -$15565.0 at Bluejay Diagnostics, up from -$42482.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $219589.0 in Q1 2023 and bottomed at -$42482.0 in Q3 2023.